Tracking the COVID-19 vaccines: The global landscape.

Tushar YadavSwatantra KumarGourav MishraShailendra K Saxena

Published in: Human vaccines & immunotherapeutics (2023)

COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; VLPs: Virus like particles; WHO: World Health Organization; E: Envelope; M: Membrane; S: Spike; N: Nucleocapsid; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses; FDA: Food and Drug Administration; LNP: lipid-nanoparticle; AZD1222: ChAdOx1 nCoV-19; BNT162b2: Pfizer-BioNTech mRNA vaccine; mRNA-1273: Moderna vaccine; Ad26.COV2.S: Johnson and Johnson - Janssen's vaccine; Gam-COVID-Vac: Sputnik Vaccine; NVX-CoV2373: Novavax vaccine with Matrix-M™ adjuvant.

Keyphrases

respiratory syndrome coronavirus
sars cov
coronavirus disease
meta analyses
systematic review
emergency department
risk assessment
single cell
adverse drug